1. Andes D, Craig WA (2001). Impact of extended-spectrum β-lactamase production on the activity of cefepime in a murine-thigh infection model, abstr. A-1099. In Abstracts and proceedings of the 41st Interscience Conference on Antimicrobial Chemotherapy. Chicago, Illinois. American Society for Microbiology, Washington DC
2. Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum beta-lactamases;Bedenic;Clin Microbiol Infect,2001
3. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae;Burgess;Diagn Microbiol Infect Dis,2004
4. Craig WA, Kiem S, Andes D, Ambrose P, Jones RN (2003). Impact of ESBLs on in vivo activity of four cephalosporins in the neutropenic mouse-thigh infection model, abstr. A-1318. In: Programs and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. American Society for Microbiology, Washington DC
5. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of β-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group;Goldstein;Antimicrob Agents Chemother,1991